Biotechnology
Healthcare
Investing News
Market News
Technology
The Market Buzz
Larimar Therapeutics FDA Clinical Hold on CTI-1601 and Termination of Recent Financing
Larimar Therapeutics, Inc. (NASDAQ: LRMR) has reported that the U.S. FDA has placed a clinical hold on the CTI-1601 clinical program and the company will not close its previously...